Livzon Pharmaceutical Group (HK:1513) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Livzon Pharmaceutical Group has announced a proposed plan to repurchase a portion of its A Shares, aiming to boost investor confidence and enhance the long-term value of its shares. The company plans to use between RMB600 million and RMB1,000 million for this buyback, which will be executed through centralized bidding on the Shenzhen Stock Exchange. The repurchased shares will be canceled to reduce the company’s registered capital, potentially affecting up to 2.44% of its total share capital.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
